Searched over 200M research papers
10 papers analyzed
These studies suggest LDL cholesterol is considered bad cholesterol due to its role in atherosclerosis and cardiovascular disease, with various factors influencing its levels and impact on health.
20 papers analyzed
Low-density lipoprotein (LDL) cholesterol is a type of cholesterol that plays a significant role in the development of coronary heart disease. It is often referred to as "bad cholesterol" because high levels of LDL cholesterol in the blood can lead to the buildup of plaques in arteries, a condition known as atherosclerosis . This buildup can restrict blood flow and increase the risk of heart attacks and strokes.
LDL cholesterol is considered bad because it contributes to the formation of atherosclerotic plaques. These plaques are not formed by native circulating LDL particles but by oxidized LDL particles that accumulate in the arterial walls. Oxidized LDL is taken up by macrophages via scavenger receptors, leading to the formation of foam cells and triggering inflammation. This inflammatory process can cause plaques to rupture, leading to thrombosis and heart attacks. Elevated levels of LDL cholesterol are strongly associated with increased cardiovascular disease risk, as seen in conditions like familial hypercholesterolemia and in patients not treated with statins .
The measurement of LDL cholesterol is crucial for evaluating the risk of coronary heart disease and the effectiveness of lipid-modifying therapies. However, different assays for measuring LDL cholesterol can yield varying results, which necessitates awareness of potential discrepancies in values.
Dietary intake of cholesterol, saturated fatty acids, and trans fatty acids can significantly impact LDL cholesterol levels. Studies have shown that increasing dietary cholesterol intake is positively associated with higher LDL cholesterol concentrations. This relationship is complex and can vary between individuals, with some models indicating a modest inverse relationship between dietary cholesterol and HDL cholesterol in men, but a positive relationship in women.
Genetic variations can also influence LDL cholesterol levels. For instance, a rare frameshift variant in the LIMA1 gene has been identified, which reduces cholesterol absorption in the intestine and maintains low plasma LDL cholesterol levels. This discovery suggests that targeting the LIMA1 pathway could be a potential strategy for managing cholesterol levels and improving heart health.
Statins are widely used to lower LDL cholesterol levels and reduce the risk of cardiovascular events. Intensive LDL cholesterol-lowering treatments, including statins, ezetimibe, and PCSK9 inhibitors, have been shown to significantly reduce the risk of major vascular events, regardless of baseline LDL cholesterol levels or the presence of comorbidities.
Recent advancements include the development of artificial platelets for the efficient delivery of siRNA targeting PCSK9, which can reduce plasma LDL cholesterol concentrations by promoting the degradation of PCSK9 and increasing LDL receptor levels. Additionally, the LXR-Idol-LDLR axis has been identified as a regulatory pathway for LDL receptor degradation, offering another potential target for controlling plasma cholesterol levels.
LDL cholesterol, often labeled as "bad cholesterol," is a critical factor in the development of atherosclerosis and cardiovascular disease. Its levels are influenced by both dietary and genetic factors, and effective management through lifestyle changes and pharmacological interventions is essential for reducing cardiovascular risk. Ongoing research continues to uncover new pathways and therapeutic strategies to better control LDL cholesterol levels and improve heart health.
Most relevant research papers on this topic